Tenet (THC) Divests Six Hospitals, Sustains Divestiture Spree
https://www.zacks.com/stock/news/2249369/tenet-thc-divests-six-hospitals-sustains-divestiture-spree?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2249369
Apr 02, 2024 - Tenet Healthcare (THC) completes the sale of six California hospitals, four to UCI Health and two to Adventist Health, to refine the portfolio and reduce debt burden.
0
3 Medical Instruments Stocks to Buy Amid Improving Industry Trends
https://www.zacks.com/commentary/2255364/3-medical-instruments-stocks-to-buy-amid-improving-industry-trends?cid=CS-ZC-FT-industry_outlook-2255364
Apr 15, 2024 - The Zacks Medical - Instruments industry is expected to gain from the rising adoption of smart healthcare options, including genAI. However, supply issues and staffing shortages continue to disrupt growth. EW, DXCM and STE appear well-poised to brave the challenges.
0
Here is Why Growth Investors Should Buy DexCom (DXCM) Now
https://www.zacks.com/stock/news/2265356/here-is-why-growth-investors-should-buy-dexcom-dxcm-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_11_growth-2265356
Apr 30, 2024 - DexCom (DXCM) is well positioned to outperform the market, as it exhibits above-average growth in financials.
0
Haemonetics (HAE) Banks on Plasma Arm Growth Amid Rising Costs
https://www.zacks.com/stock/news/2266232/haemonetics-hae-banks-on-plasma-arm-growth-amid-rising-costs?cid=CS-ZC-FT-analyst_blog|zer_report_update-2266232
May 01, 2024 - Haemonetics' (HAE) hospital portfolio is evolving and helping to create new opportunities for growth and diversification.
0
Neogen (NEOG) Unveils New Assay for Walnut Allergens Detection
https://www.zacks.com/stock/news/2192294/neogen-neog-unveils-new-assay-for-walnut-allergens-detection?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2192294
Dec 01, 2023 - Neogen's (NEOG) Veratox VIP for Walnut allergy test displays robust performance across sample types while keeping the Veratox product line's simple testing approach.
0
Community Health (CYH) Sells Three Florida Facilities for $294M
https://www.zacks.com/stock/news/2193200/community-health-cyh-sells-three-florida-facilities-for-294m?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2193200
Dec 04, 2023 - Community Health (CYH) divests three hospitals in Florida to Tampa General Hospital, substantiating its endeavor to intensify its focus on high-growth business areas.
0
BiomX (PHGE) Reports Positive Pulmonary Infection Treatment Data
https://www.zacks.com/stock/news/2192692/biomx-phge-reports-positive-pulmonary-infection-treatment-data?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2192692
Dec 04, 2023 - BiomX's (PHGE) BX004 showcases an impressive 14% conversion to a negative P. aeruginosa sputum culture at the end of treatment.
0
Here's Why You Should Retain Charles River (CRL) Stock Now
https://www.zacks.com/stock/news/2193393/here-s-why-you-should-retain-charles-river-crl-stock-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2193393
Dec 05, 2023 - Charles River's (CRL) share price is likely to grow, backed by the strength of the DSA segment.
0
Henry Schein's (HSIC) Zahn Dental and Myerson Enter New Deal
https://www.zacks.com/stock/news/2193401/henry-schein-s-hsic-zahn-dental-and-myerson-enter-new-deal?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2193401
Dec 05, 2023 - Henry Schein's (HSIC) dental laboratory business, Zahn Dental, is set to exclusively distribute Myerson's New Trusana 3D Premium Denture System.
0
West Pharmaceutical's (WST) New Launch to Expand Portfolio
https://www.zacks.com/stock/news/2193729/west-pharmaceutical-s-wst-new-launch-to-expand-portfolio?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2193729
Dec 05, 2023 - West Pharmaceutical's (WST) latest addition to its portfolio is likely to address the critical need for more drug preparation and delivery options at the point of care.
0